In the RAPA group, there were four lncRNA targets involved in the phosphoinositide 3-kinase (PI3K)-Akt pathway (ENSMUSG00000004056, ENSMUSG00000021457, ENSMUSG00000023067, and ENSMUSG00000025856), two involved in the mammalian target of rapamycin (mTOR) pathway (ENSMUSG00000004056 and ENSMUSG00000028278), and five involved in the tuberculosis pathway (ENSMUSG00000004056, ENSMUSG00000007891, ENSMUSG00000013160, ENSMUSG00000018819, and ENSMUSG00000021457). The gene discussed is AKT1; the disease is tuberculosis.